What agoko does

Histidea NV, operating under the brand agoko.be and headquartered in Sinaai, Belgium, provides a digital pathology platform (SlideSpace) alongside a broad portfolio of specialized pathology, histology, and cytology services. The company serves four primary customer segments — biopharma and pharmaceutical research, clinical laboratories, academic and institutional research organizations, and healthcare AI developers — through an enterprise-focused go-to-market with direct sales engagement and contact-based pricing. Service offerings span preclinical tissue processing and toxicology assessment, clinical trial support including central pathology review and biomarker testing, specialized analytics such as immunohistochemistry, in situ hybridization, and multiplex immunofluorescence, and a dedicated AI Development Services line covering dataset creation, expert annotation, algorithm validation, and workflow implementation.

The core technology is SlideSpace, a cloud-based digital pathology platform that enables secure slide sharing, real-time annotation and commenting, case management, and integration with laboratory information systems and AI modules. SlideSpace is delivered with end-to-end encryption, GDPR-compliant data handling, and device-agnostic access, allowing the company to position itself as a globally accessible collaboration layer. Underpinning the platform is a contracted network of over 60 board-certified pathologists with subspecialty coverage across dermatopathology, GI, gynecologic, hematopathology, neuropathology, oncologic, pulmonary, urologic pathology, cytopathology, and molecular pathology — the operating asset that converts the platform into service delivery.

Revenue is generated primarily through professional services engagements (preclinical research, clinical trial pathology support, specialized analytics, consulting, AI dataset creation, annotation, validation, and implementation support), with SlideSpace positioned as a subscription or engagement-tied platform. The company maintains named enterprise relationships with MSD, EORTC, ContextVision, Spatial Transcriptomics, TILS, BQA, the University of Antwerp, and Bonadea. Histidea is privately held with no disclosed funding rounds, parent company, or institutional investors in the available data, and reports 1–10 internal employees coordinating the broader pathologist network.

Name

agoko

Legal name

Histidea NV

Website

https://histidea.com

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Histidea (operating as agoko.be) provides the SlideSpace digital pathology platform and specialized pathology, histology, and AI development services to biopharma, clinical laboratories, research organizations, and healthcare AI developers, leveraging a network of 60+ board-certified pathologists.

Ownership category

akta.pro rank

Product category

Digital Pathology Services

NAICS

Medical and Diagnostic Laboratories (62151), Medical Laboratories (621511), Scientific Research and Development Services (5417)

SIC

Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Anatomic Pathology & Histopathology (Trial Support) (HLAGAEAC)

akta.pro secondary industries

Pathology & Histopathology Services (HLAGAFAI), Cytology & Histopathology Diagnostics (IHC, ISH, tissue-based assays) (HLAAALAI), Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB), Pathology Reporting, Synoptic Templates & Cancer Registry Interfaces (HLACAMAJ), Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays) (HLAAALAO)

Keywords

• Digital pathology services
• Histopathology analysis
• Clinical trial pathology
• AI annotation services
• Whole slide imaging

Headquarters

HQ city

Sinaai

HQ country

Belgium

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Preclinical Pathology Services: Tissue processing and analysis, toxicology assessment, efficacy evaluation, and animal model expertise for pharmaceutical research.
2. Clinical Trial Support Services: Central pathology review, biomarker testing, and pathological response assessment for pharmaceutical research clinical trials.
3. Specialized Analytics: Advanced histopathology analysis including immunohistochemistry (IHC), histochemical stains, in situ hybridization, multiplex immunofluorescence, and quantitative image analysis.
4. Consulting Services: Expert pathology consulting including study design consultation, pathology working groups, data interpretation, and laboratory optimization.
5. AI Development Services: Custom dataset creation for AI training including annotated whole slide image libraries, disease-specific datasets, and multi-modal datasets with diverse patient representation and metadata.
6. Annotation Services: Expert pathologist annotations, consensus review, semantic segmentation, and object detection for medical AI development.
7. Validation Services: Algorithm testing, comparative analysis, and edge case identification for pathology AI algorithms by expert pathologists.
8. Implementation Support: Professional support for implementing AI solutions in pathology workflows including integration consulting, performance monitoring, feedback loops, and educational programs.
9. SlideSpace Platform: Digital pathology platform subscription for collaborative workflows, potentially as part of service engagement.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Agoko (operating as Histidea NV) provides specialized pathology and histology services to biopharma, clinical laboratories, research organizations, and healthcare AI developers. Its core offering combines a network of 60+ board-certified pathologists across all subspecialties with the SlideSpace cloud-based digital pathology platform for collaborative slide review, annotation, and case management. Services span preclinical tissue evaluation, clinical trial central pathology review, biomarker testing, immunohistochemistry and multiplex immunofluorescence analytics, expert consulting, AI training dataset creation, expert annotation, algorithm validation, and implementation support.

Product overview

Histidea offers a platform-plus-services architecture combining SlideSpace (a cloud-based digital pathology platform) with specialized pathology and histology services. The SlideSpace platform enables collaborative digital pathology workflows including cloud slide access, annotation, case management, and integration with AI modules. Supporting services include preclinical pathology, clinical trial support, specialized analytics (IHC, multiplex immunofluorescence), consulting, AI dataset creation, annotation, validation, and implementation support. A network of over 60 board-certified pathologists provides expert coverage across all histopathology subspecialties.

Differentiator

Problem solved

Functional benefit

Brands

• SlideSpace: Histidea's all-inclusive platform for collaborative digital pathology workflows, enabling cloud-based slide access, secure sharing, real-time collaboration, case management, and integration with laboratory information systems and AI modules.

Products and services

• SlideSpace Digital Pathology Platform Cloud-based platform that enables pathologists and researchers to view, share, annotate, and manage whole slide images and cases from any device, with secure cloud storage, real-time collaboration, and integration with laboratory information systems and AI modules. Targeted at biopharma, clinical laboratories, research organizations, and AI developers needing collaborative pathology workflows.
• Preclinical Pathology Services Tissue processing and analysis, toxicology assessment, efficacy evaluation, and animal model pathology expertise for pharmaceutical and biotech preclinical drug development programs. Delivered by Histidea's subspecialty pathologist network.
• Clinical Trial Support Services Central pathology review, biomarker testing, and pathological response assessment services for pharmaceutical clinical trials, including digital pathology solutions for multi-site studies. Targeted at clinical trial sponsors and research organizations.
• Specialized Histopathology Analytics Advanced histopathology analysis techniques including immunohistochemistry (IHC), histochemical stains, in situ hybridization, multiplex immunofluorescence, and quantitative image analysis for research and clinical customers needing specialized staining and imaging analytics.
• Pathology Consulting Services Expert pathology consulting including study design consultation, pathology working groups, data interpretation, and laboratory organization and optimization for biopharma, research, and clinical lab clients.
• AI Dataset Creation Services Custom creation of annotated whole slide image (WSI) libraries, disease-specific datasets, and multi-modal datasets with diverse patient representation and metadata, designed to train pathology and medical imaging AI models. Targeted at healthcare AI developers.
• Pathology Annotation Services Professional annotation services by board-certified pathologists, including expert annotations, consensus review, semantic segmentation, and object detection on whole slide images for medical AI development.
• AI Validation Services Algorithm testing, comparative analysis, and edge case identification performed by expert pathologists to validate pathology AI algorithms prior to deployment. Targeted at healthcare AI developers.
• AI Implementation Support Services Professional support for implementing AI solutions in pathology workflows, including integration consulting, performance monitoring, feedback loops, and educational programs for healthcare AI customers rolling out models into clinical practice.

Named customers8 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature6 records

Partnerships

Three partnerships are on record, tiered core and minor.

• EORTC (European Organisation for Research and Treatment of Cancer)coreStrategic or Co-development PartnerMajor oncology research organization partnership for clinical pathology support and histopathology services in cancer research trials.
• MSDcoreStrategic or Co-development PartnerPharmaceutical research partnership providing pathology and histology services for clinical trial support and drug development.
• University of AntwerpminorStrategic or Co-development PartnerAcademic research collaboration with university research institution for pathology expertise and research projects.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Emerging players

• Proscia: Proscia offers a cloud-based digital pathology platform with AI integrations for life sciences and clinical use — directly competing with SlideSpace on the platform layer.
• PathAI: PathAI develops AI-powered pathology algorithms and operates a diagnostic and biopharma services business that consumes large annotated pathology datasets — comparable to Histidea on the AI services and dataset creation side.
• Indica Labs: Indica Labs provides digital pathology image analysis software (HALO) widely used in pharma research and AI workflows — competing with SlideSpace for AI-enablement and quantitative image analysis work.
• Aignostics: Aignostics is a Berlin-based AI digital pathology company combining computational pathology with pathologist expertise — overlapping with Histidea's AI development services and SlideSpace platform offering for AI developers.

Broad incumbents

• Labcorp Drug Development (formerly Covance): Labcorp's drug development arm operates one of the largest global central labs with anatomic pathology services for clinical trials — a broad incumbent competing for the same pharma trial support work as Histidea.
• Q² Solutions: Q² Solutions is a joint venture central lab offering clinical trial laboratory services including anatomic pathology and biomarker testing — a large incumbent competing in the same trial-support pathology space as Histidea.

Direct peers

• NeoGenomics: NeoGenomics provides oncology-focused pathology and biomarker services to pharma clinical trials and is a direct competitor in central pathology review and clinical trial histology support.
• Pharmatest Services: Pharmatest Services is a preclinical CRO offering in vivo efficacy, toxicology, and histopathology services — directly comparable to Histidea's preclinical pathology, toxicology assessment, and animal model expertise offerings.
• Cerba Research: Cerba Research is a central lab and specialty biomarker services provider for clinical trials, including anatomic pathology and IHC — competing with Histidea for the same biopharma central pathology and biomarker testing engagements.
• CellCarta: CellCarta (formed from the merger of HistoGeneX and Caprion) is a histopathology and biomarker services provider serving pharma clinical trials and AI developers — directly comparable to Histidea's central pathology review, IHC, multiplex immunofluorescence, and AI dataset services.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/histidea

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about agoko